Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

827.98
-15.4900-1.84%
Volume:285.67K
Turnover:238.15M
Market Cap:85.24B
PE:20.48
High:841.53
Open:840.06
Low:825.83
Close:843.47
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.44
T/O Rate:0.29%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.69
PE(LYR):19.96

Loading ...

Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Dec 09, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 19, 2019

Major Issues Report

Current report, item 5.07
May 07, 2019

Major Issues Report

[Amend] Current report, item 7.01
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 03, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Jan 09, 2018

Beneficial Ownership Change

REGENERON制药有限公司
Sep 13, 2017

Major Issues Report

REGENERON制药有限公司
Jan 31, 2017

Beneficial Ownership Change

REGENERON制药有限公司